欧洲药典适用性证书数据库（欧盟CEP认证）

专论编号	物质名称	证书持有人	持有人ORG-ID和LOC-ID	证书编号	发布日期	证书状态	到期续期	证书类型	上一程序的结束日期	历史数据程序类型\|结论\|日期
823	Etoposide	MAC CHEM PRODUCTS (INDIA) PVT. LTD. Mumbai IN	100023737;100061579	CEP 2020-074 - Rev 01	2024/04/30	Valid	25/07/2027	Chemical	2024/04/30	Administrative procedure\|CEP granted\|30/04/2024; New application\|CEP granted\|25/07/2022
2787	Esomeprazole magnesium dihydrate, Micronised	KRKA, d.d., Novo mesto Novo mesto SI	100000627;100009540	CEP 2018-035 - Rev 03	2024/04/30	Valid		Chemical	2024/04/30	Renewal\|CEP granted\|30/04/2024; Notification\|CEP granted\|05/01/2023; Notification\|CEP granted\|26/01/2022; Minor revision\|Accepted - CEP remains valid\|15/12/2020
2465	Irbesartan	ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou City CN	100012174;100018701	CEP 2012-233 - Rev 03	2024/04/30	Valid		Chemical	2024/04/30	Minor revision\|CEP granted\|30/04/2024; Minor revision\|Accepted - CEP remains valid\|01/09/2023; Notification\|Accepted - CEP remains valid\|12/05/2023; Minor revision\|Accepted - CEP remains valid\|03/06/2022; Minor revision\|CEP granted\|23/07/2021; Minor revision\|Accepted - CEP remains valid\|21/07/2020
809	Betamethasone dipropionate	TIANJIN TIANYAO PHARMACEUTICALS CO., LTD. Tianjin CN	100011805;100018616	CEP 2022-342 - Rev 00	2024/04/30	Valid	30/04/2029	Chemical	2024/04/30	New application\|CEP granted\|30/04/2024
2536	Milbemycin oxime for veterinary use	Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City CN	100011825;100018687	CEP 2021-391 - Rev 02	2024/04/30	Valid	26/07/2028	Chemical	2024/04/30	Administrative procedure\|CEP granted\|30/04/2024; Minor revision\|CEP granted\|20/11/2023; New application\|CEP granted\|26/07/2023
2125	Doxazosin mesilate, Form-I	Chemische Fabrik Berg GmbH Bitterfeld-Wolfen DE	100014200;100020038	CEP 2022-316 - Rev 00	2024/04/29	Valid	29/04/2029	Chemical	2024/04/29	New application\|CEP granted\|29/04/2024
2923	Esomeprazole sodium	SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN	100008538;100018201	CEP 2020-393 - Rev 01	2024/04/29	Valid	24/11/2027	Chemical	2024/04/29	Minor revision\|CEP granted\|29/04/2024; Minor revision\|Accepted - CEP remains valid\|28/08/2023; New application\|CEP granted\|24/11/2022
1120	Lisinopril dihydrate, Process II	HETERO DRUGS LIMITED Hyderabad IN	100008415;100014434	CEP 2016-197 - Rev 01	2024/04/29	Valid		Chemical	2024/04/29	Minor revision\|CEP granted\|29/04/2024; Minor revision\|Accepted - CEP remains valid\|09/06/2023; Renewal\|CEP granted\|28/04/2022; Minor revision\|CEP granted\|22/10/2020
2866	Gefitinib	SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou City CN	100014777;100050265	CEP 2017-028 - Rev 01	2024/04/29	Valid		Chemical	2024/04/29	Minor revision\|CEP granted\|29/04/2024; Renewal\|CEP granted\|22/03/2023; Notification\|CEP granted\|07/02/2020
1695	Granisetron hydrochloride	WAVELENGTH ENTERPRISES LTD. Petah Tikva IL	100018877;100050444	CEP 2007-217 - Rev 04	2024/04/29	Valid		Chemical	2024/04/29	Minor revision\|CEP granted\|29/04/2024; Minor revision\|Accepted - CEP remains valid\|23/02/2023; Notification\|Accepted - CEP remains valid\|14/06/2022; Minor revision\|CEP granted\|30/03/2021
1882	Passionflower herb dry extract, DER: 4-6.5:1	EUROMED S.A. Mollet del Vallès ES	100014852;100023498	CEP 2015-351 - Rev 01	2024/04/29	Valid		Herbal	2024/04/29	Monograph revision\|CEP granted\|29/04/2024; Renewal\|CEP granted\|17/08/2021; Monograph revision\|CEP granted\|24/02/2021
633	Pilocarpine hydrochloride	SPERA NEXUS, INC. Shizuoka JP	100045481;100074964	CEP 2015-343 - Rev 02	2024/04/29	Valid		Chemical	2024/04/29	Renewal\|CEP granted\|29/04/2024; Notification\|CEP granted\|06/08/2021
2135	Repaglinide	ZHEJIANG HISOAR CHUANNAN PHARMACEUTICAL CO., LTD. Taizhou City CN	100039329;100061908	CEP 2008-201 - Rev 06	2024/04/29	Valid		Chemical	2024/04/29	Notification\|CEP granted\|29/04/2024; Minor revision\|CEP granted\|12/03/2024; Notification\|CEP granted\|25/01/2022; Major revision\|CEP granted\|15/12/2021
1655	Mitomycin	HUBEI HONCH PHARMACEUTICAL CO., LTD. Huanggang CN	100036821;100058182	CEP 2022-400 - Rev 01	2024/04/26	Valid	17/04/2029	Chemical	2024/04/26	Notification\|CEP granted\|26/04/2024; New application\|CEP granted\|17/04/2024
1120	Lisinopril dihydrate, Process-III	HETERO DRUGS LIMITED Hyderabad IN	100008415;100014434	CEP 2022-434 - Rev 01	2024/04/26	Valid	04/05/2028	Chemical	2024/04/26	Minor revision\|CEP granted\|26/04/2024; New application\|CEP granted\|04/05/2023
2191	Atorvastatin calcium, Form-I	HETERO LABS LIMITED Hyderabad IN	100011681;100018664	CEP 2018-049 - Rev 02	2024/04/26	Valid	02/04/2025	Chemical	2024/04/26	Major revision\|CEP granted\|26/04/2024; Monograph revision\|CEP granted\|24/03/2023; Major revision\|Rejected\|28/03/2022
2357	Dydrogesterone, Micronised	ABBOTT HEALTHCARE PRODUCTS B.V. Weesp NL	100002995;100005756	CEP 2019-114 - Rev 01	2024/04/26	Valid	17/06/2026	Chemical	2024/04/26	Minor revision\|CEP granted\|26/04/2024; Notification\|Accepted - CEP remains valid\|14/06/2023; Notification\|Accepted - CEP remains valid\|04/04/2023; Monograph revision\|Accepted - CEP remains valid\|01/07/2022
2780	Temozolomide	FORMOSA LABORATORIES, INC. Taoyuan TW	100011879;100018688	CEP 2017-245 - Rev 01	2024/04/26	Valid		Chemical	2024/04/26	Renewal\|CEP granted\|26/04/2024; Notification\|Accepted - CEP remains valid\|07/07/2022
1244	Morphine hemisulfate 2.5-hydrate	FRANCOPIA Paris FR	100041331;100069306	CEP 2000-126 - Rev 07	2024/04/26	Valid		Chemical	2024/04/26	Monograph revision\|CEP granted\|26/04/2024; Notification\|CEP granted\|01/03/2024; Notification\|CEP granted\|02/05/2022; Notification\|Accepted - CEP remains valid\|20/02/2020
991	Ceftriaxone sodium, Sterile	ACS DOBFAR S.P.A. Tribiano IT	100011589;100019524	CEP 2011-393 - Rev 03	2024/04/26	Valid		Chemical	2024/04/26	Major revision\|CEP granted\|26/04/2024; Administrative procedure\|CEP granted\|03/03/2022; Major revision\|CEP granted\|22/02/2022

专论编号 (Monograph Number)
物质名称 (Substance)
证书持有人 (Certificate (CEP) Holder)
证书编号 (Certificate (CEP) Number)
证书类型 (Type CEP)
证书状态 (Status CEP)
发布日期(Issue Date CEP)	-
证书效期(End date CEP)	-